Geffen Residence & Renewal Ltd (TLV:GEFR)
81.20
-0.30 (-0.37%)
At close: Aug 21, 2026
TLV:GEFR Revenue
Geffen Residence & Renewal had revenue of 20.00K ILS in the quarter ending June 30, 2026, with 5.26% growth. This brings the company's revenue in the last twelve months to 79.00K, down -20.20% year-over-year. In the year 2025, Geffen Residence & Renewal had annual revenue of 78.00K, down -40.46%.
Revenue (ttm)
79.00K
Revenue Growth
-20.20%
P/S Ratio
4,228.39
Revenue / Employee
13.17K
Employees
6
Market Cap
334.04M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 78.00K | -53.00K | -40.46% |
| Dec 31, 2024 | 131.00K | -11.00K | -7.75% |
| Dec 31, 2023 | 142.00K | 82.00K | 136.67% |
| Dec 31, 2022 | 60.00K | -598.00K | -90.88% |
| Dec 31, 2021 | 658.00K | -2.01M | -75.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Evogene | 5.82M |
| BioLineRx | 4.43M |
| Can-Fite BioPharma | 1.29M |
| BioLight Life Sciences | 21.00K |
| Clal Biotechnology Industries | -118.00K |